leisure time -WSS

leisure time

author：knowledge 2025-09-29 01:46:11 - browse：4827

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021. This process, known as accelerated approval, required the company to run a confirmatory study. But ahead of an advisory panel meeting on Thursday, the agency released documents showing its staff found “potential systemic bias” in the trial.

The disclosure throws into question the future of this drug, which has offered hope to patients for whom an effective treatment previously seemed out of reach. Some Wall Street analysts are now betting the FDA will ask Amgen to run yet another trial or maybe withdraw the drug altogether. Either way, the prognosticators are reworking their calculus for Amgen stock.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Trump indictment: Who are the 'co

WSS

Vertex non

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

NIH launches clinical trials and new research office for long Covid

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Judge rejects Trump's request to move Stormy Daniels hush

Pence says 'crackpot lawyers' told Trump what he wanted to hear

knowledge

leisure time

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Wildfire pollution widens asthma inequities on Long Island

Walensky prepares to leave CDC — and Congress — behind

Mega Millions pot grows to $1.25 billion after no winner

Drug repurposing or repositioning? The language matters

Adults seen as increasingly susceptible to measles

Wildfire smoke exposes gaps in outdoor worker protections

Stanford president's case begs question: Who takes blame?

Hollywood unions extend contract negotiations for actors

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

focus

Stanford president's case begs question: Who takes blame?

Stanford president's case begs question: Who takes blame?

EQRx, failed developer of low

5 important ways Henrietta Lacks changed medical science

Mitch McConnell episode has important public health takeaway

The high personal cost of affirmative action for Black doctors

Wikipedia

focus

entertainment

knowledge